Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - weissman
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Highly Soluble Pyrimido-Dione-Quinoline Compounds: Small Molecules that Stabilize and Activate p53 in Transformed Cells
Abstract: The tumor-suppressor p53 protein plays a major role in tumor development. Most human cancers fail to normally activate wild-type p53, which is at least partly responsible for the unregulated growth of cancer cells and their failure to undergo apoptosis. While many chemotherapeutics enhance p53 levels, their non-specific DNA damage (genotoxicity)...
Published: 4/8/2024
|
Inventor(s):
Allan
Weissman
,
Yili Yang
Keywords(s):
APOPTOSIS
,
CANCER
,
HDM2 Inhibitor
,
p53 Activation
,
Weissman
Category(s):
Application > Therapeutics
,
TherapeuticArea > Oncology
,
Collaboration Sought > Licensing
,
Collaboration Sought > Collaboration
The UBE2G2 Binding Domain in the Ubiquitin Ligase GP78 and Methods of Use Thereof
Abstract: Cancer is the second leading cause of death worldwide. The primary cause of mortality from cancer is metastasis. While the underlying mechanisms of cancer metastasis are still being unraveled, the gp78 protein involved in ER-associated degradation (ERAD) appears to play a role in metastasis in sarcoma. Targeting gp78 may be a therapeutic option...
Published: 4/8/2024
|
Inventor(s):
Allan
Weissman
,
Jennifer Mariano
,
Bo Chen
,
Yien-Che Tsai
Keywords(s):
APOPTOSIS
,
CANCER
,
Endoplasmic Reticulum
,
er
,
ERAD
,
ER-associated Degradation
,
Gp78
,
Metastasis
,
STRESS
,
Ube2G2
,
Ubiquitin
,
Weissman
Category(s):
Collaboration Sought > Licensing
,
TherapeuticArea > Oncology
,
Application > Therapeutics
,
Collaboration Sought > Collaboration